These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12166512)

  • 1. Effect of sodium valproate on somatosensory evoked potentials in juvenile myoclonic epilepsy.
    Erdem H; Yiğit A; Culcuoğlu A; Mutluer N
    Ups J Med Sci; 2001; 106(3):197-203. PubMed ID: 12166512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate lowered the amplitude of visual and somatosensory evoked potentials in two cases of untreated juvenile myoclonic epilepsy.
    Kanazawa O; Nagafuji H
    Psychiatry Clin Neurosci; 1997 Dec; 51(6):425-9. PubMed ID: 9472131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery function of somatosensory evoked potentials in juvenile myoclonic epilepsy.
    Kızıltan ME; Yeni SN; Aliş C; Gündüz A
    Somatosens Mot Res; 2019 Sep; 36(3):195-201. PubMed ID: 31366264
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of the tremor in juvenile myoclonic epilepsy.
    Aydin-Özemir Z; Matur Z; Baykan B; Bilgic B; Tekturk P; Bebek N; Gurses C; Hanagasi H; Oge AE
    Epilepsy Res; 2016 Dec; 128():140-148. PubMed ID: 27835783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of praxis induction on cortical excitability in juvenile myoclonic epilepsy.
    Vidal-Dourado M; Nunes KF; Guaranha MS; Giuliano LM; Yacubian EM; Manzano GM
    Clin Neurophysiol; 2016 Jul; 127(7):2551-60. PubMed ID: 27291873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
    Calleja S; Salas-Puig J; Ribacoba R; Lahoz CH
    Seizure; 2001 Sep; 10(6):424-7. PubMed ID: 11700996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of valproate on the sleep microstructure of juvenile myoclonic epilepsy patients - a cross-sectional CAP based study.
    Nayak CS; Sinha S; Nagappa M; Kandavel T; Taly AB
    Sleep Med; 2016 Jan; 17():129-33. PubMed ID: 26847987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatosensory evoked potentials in epileptic children treated with carbamazepine or valproate in monotherapy - a preliminary study.
    Sendrowski K; Sobaniec W; Boćkowski L; Kułak W; Smigielska-Kuzia J
    Adv Med Sci; 2010; 55(2):212-5. PubMed ID: 20513644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of valproic acid resistant juvenile myoclonic epilepsy.
    Fernando-Dongas MC; Radtke RA; VanLandingham KE; Husain AM
    Seizure; 2000 Sep; 9(6):385-8. PubMed ID: 10985993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
    Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
    Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatosensory evoked potentials and EEG findings in siblings of juvenile myoclonic epilepsy patients.
    Atakli D; Soysal A; Atay T; Altintas H; Arpaci B; Baybas S
    Epileptic Disord; 1999 Sep; 1(3):173-7. PubMed ID: 10937150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
    Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
    Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surround inhibition in patients with juvenile myoclonic epilepsy.
    Turk BG; Yeni N; Gunduz A; Alis C; Kiziltan M
    Neurol Res; 2021 May; 43(5):343-348. PubMed ID: 33382016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.
    Gürer R; Aydın Ş; Özkara Ç
    Seizure; 2019 Aug; 70():43-48. PubMed ID: 31252363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalamic and cortical hyperexcitability in juvenile myoclonic epilepsy.
    Assenza G; Lanzone J; Dubbioso R; Coppola A; Boscarino M; Ricci L; Insola A; Bilo L; Tombini M; Di Lazzaro V
    Clin Neurophysiol; 2020 Aug; 131(8):2041-2046. PubMed ID: 32487476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A; Brodie MJ
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatosensory evoked potentials in juvenile myoclonic epilepsy.
    Salas-Puig J; Tuñon A; Diaz M; Lahoz CH
    Epilepsia; 1992; 33(3):527-30. PubMed ID: 1592032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
    Asadi-Pooya AA; Hashemzehi Z; Emami M
    Seizure; 2014 Nov; 23(10):889-91. PubMed ID: 25189101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal lobe cognitive functions and electroencephalographic features in juvenile myoclonic epilepsy.
    Sezikli S; Pulat TA; Tekin B; Ak PD; Keskinkılıç C; Ataklı D
    Epilepsy Behav; 2018 Sep; 86():102-107. PubMed ID: 30017834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.